title: Resolution of invasive fungal sinusitis in immunocompromised patients: neutrophil count is crucial beside a combined medical and surgical approach.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Zappasodi
authors.forename: Marianna
authors.initials: M
authors.lastname: Rossi
authors.forename: Carlo
authors.initials: C
authors.lastname: Castagnola
authors.forename: Fabio
authors.initials: F
authors.lastname: Pagella
authors.forename: Elina
authors.initials: E
authors.lastname: Matti
authors.forename: Caterina
authors.initials: C
authors.lastname: Cavanna
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bonfichi
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage*; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D006801:Humans; D016867:Immunocompromised Host; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000097:blood* / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D009504:Neutrophils; D012852:Sinusitis / Q000097:blood* / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
chemical_list: D000935:Antifungal Agents